PROCEPT BioRobotics (PRCT) Profit After Tax Growth (1y) (2021 - 2026)
PROCEPT BioRobotics (PRCT) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.21 Bn | 193.61 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 126.18 Bn | 122.71 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 118.54 Bn | 109.32 Bn | 6.41 Bn | 18.66% |
| 4 | Boston Scientific | 73.16 Bn | 72.63 Bn | 3.85 Bn | 13.84% |
| 5 | Edwards Lifesciences | 52.05 Bn | 47.79 Bn | 1.35 Bn | -27.98% |
| 6 | Dexcom | 34.46 Bn | 32.52 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 33.73 Bn | 31.63 Bn | 2.18 Bn | 14.60% |
| 8 | Koninklijke Philips | 26.33 Bn | 23.01 Bn | 4.55 Bn | 71.04% |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn | 12.92% |
| 10 | PROCEPT BioRobotics | 1.19 Bn | 919.33 Mn | 62.38 Mn | -34.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -34.68% |
| Mar 31, 2026 | -28.69% |
| Dec 31, 2025 | -58.69% |
| Sep 30, 2025 | -1.20% |
| Jun 30, 2025 | 23.60% |
| Mar 31, 2025 | 5.12% |
| Dec 31, 2024 | 31.44% |
| Sep 30, 2024 | 14.82% |
| Jun 30, 2024 | -1.35% |
| Mar 31, 2024 | 8.87% |
| Dec 31, 2023 | 3.30% |
| Sep 30, 2023 | -9.78% |
| Jun 30, 2023 | -31.80% |
| Mar 31, 2023 | -65.75% |
| Dec 31, 2022 | -55.02% |
| Sep 30, 2022 | -59.03% |
| Jun 30, 2022 | -31.58% |
| Mar 31, 2022 | -34.03% |
| Dec 31, 2021 | -19.95% |
| Sep 30, 2021 | -17.45% |